Araim Pharmaceuticals has formed a long-term strategic partnership with Vault Bioventures to facilitate the advancement to market of its novel peptide library which targets devastating injuries and chronic diseases underserved by current therapies.

See the article here:
Araim Pharmaceuticals forms new strategic collaboration with Vault Bioventures to market novel peptides

Scroll to Top